PIXARBIO CORPORATION PixarBio Corporation announced the appointment of David Kaplan as Vice President of Global Sales and Marketing. David joins PixarBio from Pacira Pharmaceuticals where he was Vice President of Sales, responsible for US sales and for leading the successful relaunch of post-op pain drug Exparel. David will report to Frank Reynolds, the company's founder and Chief Executive Officer.
David brings over twenty-five years of hands-on commercial industry experience, including thirteen years of executive sales leadership to PixarBio Corporation. His unique combination of big pharma, and start-up pharmaceutical company experience combined with his leadership style, and ability to create and sustain positive economically vibrant cultures is a perfect fit for PixarBio at this time. He was at Pacira Pharmaceuticals for the past three years, most recently as their Vice President of Sales where he was responsible for all North American Sales for the launch of Exparel.
David will develop and execute PixarBio Corporation's global sales strategy for all pre-commercial and commercial initiatives around their lead development product NeuroRelease™. David will also be responsible for the global sales strategy for all PixarBio Corporation product launches, and accountable for all facets of product roll-out and launch, sales forecasts, sales budgets, and maximizing cross-functional teams. David will work out of the PixarBio-New York Office.
